Batterham, Rachel L.

Mechanisms of weight regain.

Busetto, L., Bettini, S., Makaronidis, J., Roberts, C. A., Halford, J. C. G., & Batterham, R. L. (2021) · European Journal of Internal Medicine

Regulation of Appetite and ObesityPharmacology and Obesity Treatment

Cited by 159

New insights into the treatment of obesity

Blüher, M., Aras, M., Aronne, L. J., Batterham, R. L., Giorgino, F., Ji, L., Pietiläinen, K. H., Schnell, O., Tonchevska, E., & Wilding, J. P. H. (2023) · Diabetes, Obesity and Metabolism

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 158

Biological Control of Appetite: A Daunting Complexity

MacLean, P. S., Blundell, J. E., Mennella, J. A., & Batterham, R. L. (2017) · Obesity

Regulation of Appetite and ObesityEating Disorders and Behaviors

Cited by 140

Deletion of the von Hippel–Lindau gene in pancreatic β cells impairs glucose homeostasis in mice

Cantley, J., Selman, C., Shukla, D., Abramov, A. Y., Forstreuter, F., Esteban, M. A., Claret, M., Lingard, S. J., Clements, M., Harten, S. K., et al. (2008) · Journal of Clinical Investigation

Pancreatic function and diabetesDiabetes and associated disorders

Cited by 127

Lancet Diabetes & Endocrinology Commission on the Definition and Diagnosis of Clinical Obesity

Rubino, F., Batterham, R. L., Koch, M., Mingrone, G., le Roux, C. W., Farooqi, I. S., Farpour-Lambert, N., Gregg, E. W., & Cummings, D. E. (2023) · The Lancet Diabetes & Endocrinology

Obesity and Health PracticesObesity, Physical Activity, Diet

Cited by 126

Two‐year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5

Wharton, S., Batterham, R. L., Bhatta, M., Buscemi, S., Christensen, L. N., Frias, J. P., Jódar, E., Kandler, K., Rigas, G., Wadden, T. A., et al. (2023) · Obesity

Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity

Cited by 124

The role of gut hormone peptide YY in energy and glucose homeostasis: Twelve years on

Manning, S., & Batterham, R. L. (2014) · Annual Review of Physiology

Regulation of Appetite and ObesityNeuropeptides and Animal Physiology

Cited by 124

Impact of Semaglutide on Body Composition in Adults With Overweight or Obesity: Exploratory Analysis of the STEP 1 Study

Wilding, J. P. H., Batterham, R. L., Calanna, S., Van Gaal, L. F., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wharton, S., Yokote, K., Zeuthen, N., et al. (2021) · Journal of the Endocrine Society

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 107

Reported Appetite, Taste and Smell Changes Following Roux-En-Y Gastric Bypass and Sleeve Gastrectomy: Effect of Gender, Type 2 Diabetes and Relationship to Post-Operative Weight Loss

Makaronidis, J. M., Neilson, S., Cheung, W.-H., Tymoszuk, U., Pucci, A., Finer, N., Doyle, J., Hashemi, M., Elkalaawy, M., Adamo, M., et al. (2016) · Appetite

Bariatric Surgery and OutcomesRegulation of Appetite and Obesity

Cited by 94

Calorie restriction and not glucagon‐like peptide‐1 explains the acute improvement in glucose control after gastric bypass in Type 2 diabetes

Steven, S., Hollingsworth, K. G., Small, P. K., Woodcock, S. A., Pucci, A., Aribasala, B., Al‐Mrabeh, A., Batterham, R. L., & Taylor, R. (2016) · Diabetic Medicine

Bariatric Surgery and OutcomesDiabetes Treatment and Management

Cited by 71

The implications of defining obesity as a disease: a report from the Association for the Study of Obesity 2021 annual conference

Luli, M., Yeo, G., Farrell, E., Ogden, J., Parretti, H., Frew, E., Bevan, S., Brown, A., Logue, J., Menon, V., et al. (2023) · eClinicalMedicine

Obesity and Health PracticesObesity, Physical Activity, Diet

Cited by 66

Predictors of ≥15% weight reduction and associated changes in cardiometabolic risk factors with tirzepatide in adults with type 2 diabetes in SURPASS 1-4

Małecki, M. T., Batterham, R. L., Sattar, N., Levine, J. A., Rodríguez, Á., Bergman, B. K., Wang, H., Ghimpeteanu, G., & Lee, C. J. (2023) · Diabetes Care

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 52

Effect of semaglutide 2.4 mg once weekly on 10‐year type 2 diabetes risk in adults with overweight or obesity

Wilkinson, L., Holst‐Hansen, T., Laursen, P. N., Rinnov, A. R., Batterham, R. L., & Garvey, W. T. (2023) · Obesity

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 25